JP Morgan Chase
BFRI icon

JP Morgan Chase’s Biofrontera BFRI Stock Holding History

JP Morgan Chase’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-197
Closed -$158 – 7082
2025
Q1 		$158 Buy
+197
New +$203 ﹤0.01% 6824
2024
Q1 		– Sell
-825
Closed -$2.29K – 7409
2023
Q4 		$2.29K Buy
825
+824
+82,400% +$3.6K ﹤0.01% 6704
2023
Q3 		$9 Buy
+1
New +$10 ﹤0.01% 7304

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's BFRI Position: Q2 2025 in Review

JP Morgan Chase sold out of Biofrontera (BFRI) in Q2 2025, closing a stake of 197 shares — an estimated $158 sold.

JP Morgan Chase first reported a position in BFRI in Q3 2023 and held it in 3 quarters. The position peaked at $2.29K in Q4 2023. 10 funds tracked by Wall St. Rank hold BFRI as of Q2 2025.

  • JP Morgan Chase reported no remaining Biofrontera position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 197 Biofrontera shares in Q2 2025, an estimated $158.
  • JP Morgan Chase first reported a position in Biofrontera in Q3 2023 and held it in 3 quarters.
  • JP Morgan Chase's Biofrontera position peaked at $2.29K in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Biofrontera as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.